Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This update represents a small internal version change and does not alter study information or user-facing content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe website revision was updated from v3.6.3 to v3.6.4, representing a newer platform release. There is no change to study data or page content reflected.SummaryDifference0.1%

- Check44 days agoChange DetectedThe revision indicator was updated from v3.6.2 to v3.6.3. This reflects an underlying site update but does not alter the study details or the information presented to users.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. No user-facing content changes are indicated.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now states recruitment has ended and introduces new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with the Intervention/Treatment heading and a revised revision tag (Revision: v3.6.0).SummaryDifference0.6%

- Check72 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. This indicates a small platform update with no change to the study information shown.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.